Advertisement
Canada markets open in 4 hours 21 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7268
    +0.0005 (+0.07%)
     

  • CRUDE OIL

    83.05
    +0.32 (+0.39%)
     

  • Bitcoin CAD

    88,881.43
    +4,322.49 (+5.11%)
     

  • CMC Crypto 200

    1,330.22
    +17.59 (+1.34%)
     

  • GOLD FUTURES

    2,399.10
    +1.10 (+0.05%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,412.50
    -134.75 (-0.77%)
     

  • VOLATILITY

    19.93
    +1.93 (+10.72%)
     

  • FTSE

    7,818.32
    -58.73 (-0.75%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6821
    0.0000 (0.00%)
     

Top Ranked Momentum Stocks to Buy for November 14th

Zacks Equity Research
Updated

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 14th:

Take-Two Interactive Software, Inc. (TTWO): This developer of interactive entertainment solutions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 26.5% over the last 60 days.

Take-Two Interactive Software, Inc. Price and Consensus

Take-Two Interactive Software, Inc. Price and Consensus | Take-Two Interactive Software, Inc. Quote

Take-Two Interactive Software’s shares gained 13.1% over the last one month more than S&P 500’s gain of 1.2%. The company possesses a Momentum Score of A.

ADVERTISEMENT

Take-Two Interactive Software, Inc. Price

Take-Two Interactive Software, Inc. Price
Take-Two Interactive Software, Inc. Price

Take-Two Interactive Software, Inc. price | Take-Two Interactive Software, Inc. Quote

Collegium Pharmaceutical, Inc. (COLL): This developer of abuse-deterrent products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 12.3% over the last 60 days.

Collegium Pharmaceutical, Inc. Price and Consensus

Collegium Pharmaceutical, Inc. Price and Consensus | Collegium Pharmaceutical, Inc. Quote

Collegium Pharmaceutical’s shares gained 28.6% over the last one month. The company possesses a Momentum Score of A.

Collegium Pharmaceutical, Inc. Price

Collegium Pharmaceutical, Inc. Price
Collegium Pharmaceutical, Inc. Price

Collegium Pharmaceutical, Inc. price | Collegium Pharmaceutical, Inc. Quote

Allison Transmission Holdings, Inc. (ALSN): This manufacturer of fully-automatic transmissions has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.1% over the last 60 days.

Allison Transmission Holdings, Inc. Price and Consensus

Allison Transmission Holdings, Inc. Price and Consensus | Allison Transmission Holdings, Inc. Quote

Allison Transmission Holdings’ shares gained 13% over the last one month. The company possesses a Momentum Score of A.

Allison Transmission Holdings, Inc. Price

Allison Transmission Holdings, Inc. Price
Allison Transmission Holdings, Inc. Price

Allison Transmission Holdings, Inc. price | Allison Transmission Holdings, Inc. Quote

Kennametal Inc. (KMT): This developer of tungsten carbides and ceramics has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 13.2% over the last 60 days.

Kennametal Inc. Price and Consensus

Kennametal Inc. Price and Consensus | Kennametal Inc. Quote

Kennametal’s shares gained 3.6% over the last one month. The company possesses a Momentum Score of A.

Kennametal Inc. Price

Kennametal Inc. Price
Kennametal Inc. Price

Kennametal Inc. price | Kennametal Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Take-Two Interactive Software, Inc. (TTWO) : Free Stock Analysis Report
 
Kennametal Inc. (KMT) : Free Stock Analysis Report
 
Collegium Pharmaceutical, Inc. (COLL) : Free Stock Analysis Report
 
Allison Transmission Holdings, Inc. (ALSN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.